Details for 2019778516

Up to date per 03.04.2026

Actions

Title / Product Name

INFIGRATINIB ZUR BEHANDLUNG VON FGFR3-BEDINGTEN SKELETTERKRANKUNGEN WÄHREND DER SCHWANGERSCHAFT

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2019778516

EP Publication Number

3856187

E-Number

1774474

Language

PCT Number

EP19076241

Publication Date

04.08.2021 A

12.03.2025 B1

Registration Date

12.03.2025

AT Publication Date

15.04.2025

Application Date

27.09.2019

Registration Number

Priorities

28.09.2018

18306275

IPC

A61K 31/506 20060101AFI20200403BHEP

Maximum Duration of Protection

27.09.2039

Owner

Institut National de la Santé et de la Recherche Médicale (INSERM)101 rue de Tolbiac 75013 ParisFR

Université Paris Cité85 boulevard Saint-Germain 75006 ParisFR

ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS55 boulevard Diderot 75012 Paris 12FR

Fondation Imagine24, Boulevard du Montparnasse 75015 ParisFR

Representative

No representatives present

Inventor

LEGEAI-MALLET, LaurenceINSERM U1163 - Institut Imagine 24 Boulevard du Montparnasse 75015 PARISFR